CHLORDIAZEPOXIDE MARKET

INTRODUCTION

Chlordiazepoxide, trade name Librium among others, is asedativeandhypnoticmedication of thebenzodiazepineclass; it is used to treatanxiety,insomniaand symptoms ofwithdrawalfromalcoholand other drugs.

Chlordiazepoxide has a medium to longhalf-lifebut itsactive metabolitehas a very long half-life. The drug hasamnesic,anticonvulsant,anxiolytic,hypnotic,sedativeandskeletal muscle relaxantproperties.

Chlordiazepoxide was patented in 1958 and approved for medical use in 1960. It was the firstbenzodiazepineto be synthesized and the discovery of Chlordiazepoxide was by pure chance.

Chlordiazepoxide and other benzodiazepines were initially accepted with widespread public approval but were followed with widespread public disapproval and recommendations for more restrictive medical guidelines for its use.

Chlordiazepoxide is indicated for the short-term (2–4 weeks) treatment of anxiety that is severe and disabling or subjecting the person to unacceptable distress. It is also indicated as a treatment for the management of acutealcohol withdrawal syndrome.

It can sometimes be prescribed to ease symptoms ofirritable bowel syndromecombined with clidinium bromide as a fixed dose medication,Librax.

CHLORDIAZEPOXIDE MARKET SIZE AND FORECAST

The Global Chlordiazepoxide market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

CHLORDIAZEPOXIDE MARKETNEW PRODUCT LAUNCH

Anispas - Chlordiazepoxide belongs to a group of medicines called benzodiazepine anxiolytics indicated for the management of anxiety disorders.

Additionally, Chlordiazepoxide is used for the short-term relief of muscle spasms, symptoms of alcohol withdrawal, anxiety-causing insomnia or distress, and anxiety occurring with mental health problems.

Chlordiazepoxide contains ‘Chlordiazepoxide’, which works by increasing the action of a chemical messenger called GABA.

This helps suppress the excessive and abnormal activity of the nerve cells in the brain. Thereby, Chlordiazepoxide helps in treating anxiety.

Chlordiazepoxide may interact with pain killers (carisoprodol, hydrocodone, methadone, codeine, morphine), sedative-hypnotic (zolpidem), benzodiazepine (alprazolam, clonazepam, diazepam), anti-hypertensive (metoprolol), anti-depressants (amitriptyline, citalopram, escitalopram, duloxetine), anti-histamine (hydroxyzine), anti-epileptic (phenytoin, phenobarbitone), anti-TB (rifampicin), antacid (cimetidine, omeprazole, disulfiram), muscle relaxant (baclofen), cardiac glycosides (digoxin), vasodilators (hydralazine, minoxidil), blood thinner (warfarin), and diuretic medication (furosemide).

Avoiding or handling machinery as Chlordiazepoxide may cause drowsiness, impaired concentration, blurred vision, and impaired muscular function. Avoid consumption of alcohol while taking Chlordiazepoxide as it may cause increased drowsiness. Chlordiazepoxide should not be given to children as safety and effectiveness were not established. 

CHLORDIAZEPOXIDE MARKETCOMPANY PROFILE

• Sun Pharmaceutical Industries
• Divis Laboratories
• Cipla 
• Dr. Reddys Laboratories 
• Apollo Hospitals Enterprise 

THISCHLORDIAZEPOXIDE MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Chlordiazepoxide are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Chlordiazepoxide and key vendor selection criteria
3. Where is the Chlordiazepoxide manufactured? What is the average margin per unit?
4. Market share of Global Chlordiazepoxide market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Chlordiazepoxide in-house
6. key predictions for next 5 years in Global Chlordiazepoxide market
7. Average B-2-B Chlordiazepoxide market price in all segments
8. Latest trends in Chlordiazepoxide market, by every market segment
9. The market size (both volume and value) of the Chlordiazepoxide market in 2024-2030 and every year in between?
10. Production breakup of Chlordiazepoxide market, by suppliers and their OEM relationship